Tommy G.  Thompson net worth and biography

Tommy Thompson Biography and Net Worth

Governor Thompson was appointed to our Board in connection with our initial public offering (“IPO”) in July 2013 and is the non-executive chairman of our Board and a member of the compensation committee, nominating and corporate governance committee, and the finance and investment committee.

Governor Thompson is currently serving as the University of Wisconsin System interim President. Governor Thompson is the former United States Health and Human Services (HHS) Secretary, serving from 2001 to 2005, and a four-term Governor of Wisconsin. Following his terms in public office, Governor Thompson built, and continues to build, on his efforts as HHS Secretary and Governor to develop innovative solutions to the health care challenges facing American families, businesses, communities, states, and the nation. These efforts focus on improving the use of information technology in hospitals, clinics, and doctors’ offices; promoting healthier lifestyles; strengthening and modernizing Medicare and Medicaid; and expanding the use of medical diplomacy around the world.

From 2005 until 2009, Governor Thompson served as a senior advisor at the consulting firm Deloitte & Touche USA LLP and was the founding independent chairman of the Deloitte Center for Health Solutions, which researches and develops solutions to some of our nation’s most pressing health care and public health-related challenges. From 2005 to early 2012, Governor Thompson served as a senior partner at the law firm of Akin Gump Strauss Hauer & Feld LLP. Governor Thompson served as Chairman of the Board of Trustees of Logistics Health, Inc. from January 2007 to May 2011, and served as President from February 2005 to January 2011. Governor Thompson served on the Board of Directors of Centene Corporation from 2005 to 2022.

Governor Thompson currently serves on the Board of Directors of United Therapeutics Corporation (since 2010) and TherapeuticsMD, Inc. (since 2012). Governor Thompson was formerly a director of C.R. Bard, Inc., Cytori Therapeutics, Inc., Cancer Genetics, Inc., CareView Communications, Inc., and Tyme Technologies, Inc. Governor Thompson received his B.S. and J.D. from the University of Wisconsin-Madison.

What is Tommy G. Thompson's net worth?

The estimated net worth of Tommy G. Thompson is at least $358,709.20 as of December 13th, 2022. Mr. Thompson owns 19,060 shares of Healthpeak Properties stock worth more than $358,709 as of April 27th. This net worth evaluation does not reflect any other investments that Mr. Thompson may own. Learn More about Tommy G. Thompson's net worth.

How do I contact Tommy G. Thompson?

The corporate mailing address for Mr. Thompson and other Healthpeak Properties executives is 309 N. WATER STREET SUITE 500, MILWAUKEE WI, 53202. Healthpeak Properties can also be reached via phone at (414) 367-5600 and via email at [email protected]. Learn More on Tommy G. Thompson's contact information.

Has Tommy G. Thompson been buying or selling shares of Healthpeak Properties?

Tommy G. Thompson has not been actively trading shares of Healthpeak Properties in the last ninety days. Most recently, on Tuesday, December 13th, Tommy G. Thompson bought 17,760 shares of Healthpeak Properties stock. The stock was acquired at an average cost of $15.16 per share, with a total value of $269,241.60. Following the completion of the transaction, the director now directly owns 19,060 shares of the company's stock, valued at $288,949.60. Learn More on Tommy G. Thompson's trading history.

Who are Healthpeak Properties' active insiders?

Healthpeak Properties' insider roster includes Laurie Becker (SVP), Albert Black, Jr. (Director), Daniel Klein (SVP), Bradley Page (SVP), Pamela Shelley-Kessler (Director), Jeffrey Theiler (CFO), John Thomas (President & CEO), and Tommy Thompson (Director). Learn More on Healthpeak Properties' active insiders.

Are insiders buying or selling shares of Healthpeak Properties?

During the last year, Healthpeak Properties insiders bought shares 1 times. They purchased a total of 2,264 shares worth more than $30,020.64. During the last year, insiders at the real estate investment trust sold shares 1 times. They sold a total of 22,322 shares worth more than $300,677.34. The most recent insider tranaction occured on September, 14th when SVP Laurie P Becker sold 22,322 shares worth more than $300,677.34. Insiders at Healthpeak Properties own 0.3% of the company. Learn More about insider trades at Healthpeak Properties.

Information on this page was last updated on 9/14/2023.

Tommy G. Thompson Insider Trading History at Healthpeak Properties

Transaction DateBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
12/13/2022Buy17,760$15.16$269,241.6019,060View SEC Filing Icon  
5/9/2018Buy1,300$15.22$19,786.0082,289View SEC Filing Icon  
3/6/2018Buy13,650$14.71$200,791.50View SEC Filing Icon  
12/14/2017Buy2,705$18.46$49,934.3049,339View SEC Filing Icon  
11/23/2016Buy2,100$18.05$37,905.0032,938View SEC Filing Icon  
11/17/2016Buy14,400$18.04$259,776.0030,838View SEC Filing Icon  
8/31/2015Buy1,000$14.71$14,710.00View SEC Filing Icon  
12/11/2014Buy1,900$15.88$30,172.00View SEC Filing Icon  
5/27/2014Buy4,000$12.50$50,000.00View SEC Filing Icon  
See Full Table

Tommy G. Thompson Buying and Selling Activity at Healthpeak Properties

This chart shows Tommy G Thompson's buying and selling at Healthpeak Properties by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Healthpeak Properties Company Overview

Healthpeak Properties logo
Healthpeak Properties, Inc. is a fully integrated real estate investment trust (REIT) and S&P 500 company. Healthpeak owns, operates, and develops high-quality real estate for healthcare discovery and delivery.
Read More

Today's Range

Now: $18.82
Low: $18.34
High: $19.05

50 Day Range

MA: $16.66
Low: $10.90
High: $19.34

2 Week Range

Now: $18.82
Low: $15.24
High: $22.38

Volume

7,081,718 shs

Average Volume

5,415,402 shs

Market Capitalization

$13.35 billion

P/E Ratio

53.77

Dividend Yield

6.54%

Beta

1.02